Skip to content

Clinical trials

Recruiting Neoplasm Metastasis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Recruiting Country / region: Netherlands Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20191
20202
20223
20236
20245
20258
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
The Netherlands Cancer Institute3
AstraZeneca2
Merck Sharp & Dohme LLC2
Nuvalent Inc.2
AVEO Pharmaceuticals, Inc.1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Academisch Ziekenhuis Maastricht1
Cogent Biosciences, Inc.1
Exelixis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis29
Colorectal Neoplasms4
Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Endometrial Neoplasms3
Lung Neoplasms3
Breast Neoplasms2
Bronchial Neoplasms2
Carcinoma, Hepatocellular2
Gastrointestinal Stromal Tumors2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.